2021 Pharmaceutical Companies Vaccines 
The Pharmacist
NOVEMBER 1, 2023
Ensuring good access and information around vaccinations is ‘key’ to tackling health inequalities, director of market access and policy affairs at Moderna told delegates at a Westminster Health Forum this week.
pharmaphorum
JANUARY 31, 2022
It is becoming increasingly important for people all over the world to understand the importance of vaccines and to have access to the vaccines they need – especially with digital innovation driving new vaccine development. Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine awareness, access, and innovation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 31, 2023
Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. This has led pharmaceutical equipment manufacturers to react quickly, while maintaining due levels of diligence and social responsibility.
Pharma Mirror
SEPTEMBER 11, 2022
Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.
Pharmaceutical Technology
APRIL 25, 2023
As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.
Pharmaceutical Technology
APRIL 21, 2023
US-based biopharmaceutical company Blue Water Vaccines has signed an asset purchase agreement with Veru to buy its Entadfi (finasteride and tadalafil) capsules business, for a total consideration of $100m. The US Food and Drug Administration granted approval to Entadfi for the treatment of BPH in December 2021.
pharmaphorum
JANUARY 16, 2023
With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. which helped to make the shots after being urged to do so by the US government, the Biden administration in March 2021 hailing the collaboration ‘historic’.
Expert insights. Personalized for you.
84 
Let's personalize your content